Unlock instant, AI-driven research and patent intelligence for your innovation.
Application of young blood plasma exosome in preparation of medicine for treating senescence-induced degenerative diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for degenerative diseases, young people, applied in the biological field, can solve problems such as mitochondrial function decline
Pending Publication Date: 2022-07-15
NANJING YOUZHIYUAN PHARMACEUTICAL TECHNOLOGY CO LTD +1
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, degenerative diseases caused by aging are mostly aimed at specific targets, which are single and drug-dependent, and cannot fundamentally alleviate the decline of mitochondrial function caused by aging
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0018] Example 1 Extraction of plasma exosomes
[0019] The method of the above-mentioned plasma exosome extraction kit comprises the following steps:
[0021] (2) Set the water bath to 37°C half an hour before the operation.
[0022] (3) Take out the subpackaged frozen plasma, thaw in a water bath at 25-37°C, and place it on ice after thawing.
[0023] (4) Centrifuge at 500g for 5 minutes at 4°C, and take the supernatant.
[0024] (5) Centrifuge at 3000g for 25 minutes at 4°C, and take the supernatant.
[0025] (6) Centrifuge at 10,000g for 60 minutes at 4°C, and take the supernatant.
[0026] (7) First add an appropriate amount of PBS to the 15ml centrifuge tube to dilute, try not to have air bubbles.
[0027] (8) Pour the plasma into the centrifuge tube without air bubbles. Rinse the tube wall and tube cover without air bubbles. The mark faces outward and sli...
Embodiment 2
[0037] After extracting the plasma exosomes from young mice, the exosomes were injected into the old C57BL / 6J mice according to the plasma exosome injection procedure shown in Example 1, and then the mouse hippocampus and muscle tissue proteins were extracted and detected by western bolt Changes of differentially expressed genes in each tissue, see the results figure 1 .
Embodiment 3
[0039] After the plasma exosomes were extracted, the exosomes were co-cultured with nerve cells (NE4C) and muscle cells (C2C12), respectively, and the following indicators were detected after 24 hours:
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to an application of a young plasmaexosome in preparation of a medicine for treating degenerative diseases caused by senescence. The exosome extracted from blood plasma of young people is used for treating degenerative diseases caused by aging, and has the advantages of obvious effect, low treatment cost, easiness in storage of the kit and the like; the technical method for treating mitochondrial dysfunction caused by aging by relying on young plasma exosomes solves the problems of high production cost, single target spot and the like of the existing neurodegenerative disease medicines to a great extent, and is a low-cost and high-efficiency neurodegenerative disease treatment mode; meanwhile, the safety of an exosome treatment mode based on the invention is proved. The method can be widely applied to related work such as treatment of senescence-induced degenerative diseases, and becomes an effective means for treatment of senescence-induced degenerative diseases.
Description
technical field [0001] The invention belongs to the field of biotechnology, and relates to the application of young plasma exosomes in the preparation of medicines for treating degenerative diseases caused by aging. Background technique [0002] With the increase of age, aging will occur in many organs, such as the brain, muscles, bones, etc., among which the degenerative changes of the nervous system are the most obvious. As the degenerative changes of organs gradually intensify, it will eventually lead to a series of functional disorders such as the nervous system and motor system, which are called degenerative diseases. At present, degenerative diseases mainly include Alzheimer's disease (AD), Multiple sclerosis (MS), Parkinson's Disease (PD), Amyotrophic lateral sclerosis (Amyotrophic lateral sclerosis, ALS), Huntington disease (HD), and different types of Spinocerebellar Atrophy (SCA). [0003] As one of the components of the circulatory system, blood plays a variety ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/16A61P39/06A61P25/28
CPCA61K35/16A61P39/06A61P25/28
Inventor 朱卿骆阳陈骁锐
Owner NANJING YOUZHIYUAN PHARMACEUTICAL TECHNOLOGY CO LTD